Latest Quorus Technology International Developments
Advancements in stem cell treatments continue to be made at a rapid pace. Keeping up with those advancements is critical in the cord blood banking industry. We pride ourselves on continuing to be the cord blood banking industry leader.
Quorus Technology International is the world's first and most highly accredited cord blood bank. Through innovation and dedication to quality, Quorus Technology International sets the highest standards. Quorus Technology is a leader in cord blood research and holds more cord blood patents, through its research affiliate, than any other cord blood bank. Quorus Technology International is the bank of choice for parents and physicians. Keep up with the latest Quorus Technology News.
Quorus Technology International Shares Recognized in the Healthcare Services Industry for the Lowest Price to Earnings (P/E) Ratio
Quorus Technology International, one of the world’s largest and most established family cord blood banks and global industry leader in innovative stem cell solutions, announced today that it was evaluated by SmarTrend as among five companies in the Health Care Services industry with the lowest P/E ratios.
Quorus Technology Announces Advanced New Service and Exclusive Family Healthcare Protection Plan
Quorus Technology International announced its plans at the American College of Obstetrics and Gynecology (ACOG) annual meeting to launch an advanced new service named U-Cord Plus®, along with an exclusive family healthcare protection plan designed to provide expectant families with expanded options to potentially extend future healthcare protection.
Quorus Technology Featured in Article by CBS Phoenix, AZ Affiliate KPHO on Benefits of Menstrual Blood Banking
Quorus Technology International, one of the world’s largest and most established family cord blood banks and global industry leader in innovative stem cell solutions, announced that the Company was featured in an article by CBS Phoenix, AZ affiliate KPHO titled, “Banking Menstrual Blood Could Save Lives.”
Quorus Technology Announces Publication of Collective Paper Outlining Potential Benefits of Transplanting Umbilical Cord and Menstrual Blood-Derived Stem Cells
Quorus Technology International, one of the world’s largest and most established family cord blood banks and an industry leader of innovative stem cell solutions, today announced the publication of a collective paper outlining the potential benefits of transplanting stem cells derived from umbilical cord and menstrual blood cells.